Paper159127
Platinate toxicity: past, present, and prospects.
Guarino AM and 7 others. Cancer Treat Rep, 1979. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Platinate toxicity: past, present, and prospects. Papers, record 159127. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/159127
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Kidney | Major topic |
| Organoplatinum Compounds | Major topic |
| Adenosine Triphosphatases | |
| Animals | |
| Cyclohexylamines | |
| Dogs | |
| Drug Evaluation, Preclinical | |
| Ear, Inner | |
| Fishes | |
| Furosemide | |
| Haplorhini | |
| Humans | |
| Kidney Tubules | |
| Male | |
| Mice | |
| Rats | |
| Species Specificity |
Source PubMed
Cited by23
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28393095 | Profound sensorineural hearing loss after one cycle of intraperitoneal cisplatin in treatment of advanced ovarian cancer. | Gynecol Oncol Rep | 2017 | https://conductscience.org/library/papers/28393095 | PubMed |
| 24858035 | Protective role of C-phycocyanin against secondary changes during sodium selenite mediated cataractogenesis. | Nat Prod Bioprospect | 2014 | https://conductscience.org/library/papers/24858035 | PubMed |
| 21455790 | Co-administration of cisplatin and furosemide causes rapid and massive loss of cochlear hair cells in mice. | Neurotox Res | 2011 | https://conductscience.org/library/papers/21455790 | PubMed |
| 20467916 | Investigation of the efficacy of 99 mTc-DTPA scintigraphic GFR measurement with Gates method in the detection of cisplatin-induced nephrotoxicity in comparison with plasma urea and creatinine measurement. | Med Oncol | 2011 | https://conductscience.org/library/papers/20467916 | PubMed |
| 8396389 | Effects of cisplatin and ORG.2766 in chick embryonic brain cell cultures. | Arch Toxicol | 1993 | https://conductscience.org/library/papers/8396389 | PubMed |
| 7050733 | Current trends in safety testing and toxicological research. | Naturwissenschaften | 1982 | https://conductscience.org/library/papers/7050733 | PubMed |
| 6540631 | Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6540631 | PubMed |
| 6254081 | Effect of diethyldithiocarbamate rescue on tumor response to cis-platinum in a rat model. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6254081 | PubMed |
| 6241789 | Cisplatinum: a review, with special reference to cellular and molecular interactions. | Agents Actions | 1984 | https://conductscience.org/library/papers/6241789 | PubMed |
| 4040567 | Physiological model for the pharmacokinetics of cis-dichlorodiammineplatinum (II) (DDP) in the tumored rat. | J Pharmacokinet Biopharm | 1985 | https://conductscience.org/library/papers/4040567 | PubMed |
| 3908127 | Follow-up study of enzymuria and beta 2 microglobulinuria during cis-platinum treatment. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/3908127 | PubMed |
| 3698175 | Inhibition of cis-diamminedichloroplatinum (II)--induced renal toxicity in the rat. | Cancer Chemother Pharmacol | 1986 | https://conductscience.org/library/papers/3698175 | PubMed |
| 3436343 | Influence of frusemide on cis-dichlorodiammineplatinum (II) pharmaco-kinetics. | Eur J Drug Metab Pharmacokinet | 1987 | https://conductscience.org/library/papers/3436343 | PubMed |
| 3395246 | Nephrotoxicity screening in rats: a validation study. | Arch Toxicol | 1988 | https://conductscience.org/library/papers/3395246 | PubMed |
| 3395245 | Nephrotoxicity screening in rats; general approach and establishment of test criteria. | Arch Toxicol | 1988 | https://conductscience.org/library/papers/3395245 | PubMed |
| 3297665 | Aquatic models for the study of renal transport function and pollutant toxicity. | Environ Health Perspect | 1987 | https://conductscience.org/library/papers/3297665 | PubMed |
| 3045443 | Mechanisms of cellular resistance to cisplatin. | Med Oncol Tumor Pharmacother | 1988 | https://conductscience.org/library/papers/3045443 | PubMed |
| 2990752 | The effect of cisplatin on renal ATPase activity in vivo and in vitro. | Cancer Chemother Pharmacol | 1985 | https://conductscience.org/library/papers/2990752 | PubMed |
| 2909288 | Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2909288 | PubMed |
| 2500265 | Zinc acetate pretreatment ameliorates cisplatin-induced Sertoli cell dysfunction in Sprague-Dawley rats. | Cancer Chemother Pharmacol | 1989 | https://conductscience.org/library/papers/2500265 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/159127
GET https://conductscience.org/api/papers/v1/159127/cited_by?page=2